Quick Answer
MARIMED INC. reported Total Revenue of $159.83 million for fiscal year 2025.
MARIMED INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $159.83M +1.3% |
$157.71M +6.1% |
$148.60M +10.9% |
$134.01M +10.3% |
$121.46M +138.7% |
$50.90M +11.6% |
| Revenue (ASC 606) | $159.83M +1.3% |
$157.71M +6.1% |
$148.60M +10.9% |
$134.01M +10.3% |
$121.46M | — |
| Net Income | -$14.48M -16.2% |
-$12.47M +22.2% |
-$16.03M -219.0% |
$13.47M +86.4% |
$7.22M +237.0% |
$2.14M +102.6% |
| Diluted EPS | -$0.04 -33.3% |
-$0.03 +25.0% |
-$0.04 -200.0% |
$0.04 +100.0% |
$0.02 +100.0% |
$0.01 +102.6% |
| Total Assets | $202.56M -2.1% |
$206.99M +5.5% |
$196.12M +28.9% |
$152.20M +23.5% |
$123.20M +61.2% |
$76.45M +24.2% |
| Cash and Equivalents | — | $7.28M -50.3% |
$14.64M +50.4% |
$9.74M -67.2% |
$29.68M +889.7% |
$3.00M +306.0% |
| Stockholders Equity | $50.01M -14.6% |
$58.55M -15.0% |
$68.89M +20.2% |
$57.31M +57.9% |
$36.30M +348.1% |
$8.10M +28.0% |
| R&D Expense | — | — | — | — | — | — |
| Operating Income | -$2.82M -208.1% |
$2.61M -81.9% |
$14.38M -29.4% |
$20.37M -24.2% |
$26.86M +84.9% |
$14.53M +135.0% |
| Gross Profit | $57.88M -7.6% |
$62.61M -5.0% |
$65.92M +3.1% |
$63.96M -3.5% |
$66.26M +111.5% |
$31.32M +67.5% |
| Shares Outstanding | 396.91M +4.0% |
381.48M +1.7% |
375.13M +9.9% |
341.47M +2.2% |
334.03M +6.2% |
314.42M +37.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $40.76M | +0.4% | +2.9% |
| Revenue (ASC 606) | September 30, 2025 | $40.76M | +0.4% | +2.9% |
| Net Income | September 30, 2025 | -$2.95M | -193.0% | -132.3% |
| Diluted EPS | September 30, 2025 | -$0.01 | — | — |
| Total Assets | September 30, 2025 | $205.60M | -3.3% | +0.6% |
| Cash and Equivalents | September 30, 2025 | $6.60M | -32.6% | +7.5% |
| Stockholders Equity | September 30, 2025 | $54.32M | -18.4% | -4.6% |
| Operating Income | September 30, 2025 | $1.60M | +18.9% | +40.1% |
| Gross Profit | September 30, 2025 | $16.36M | -2.5% | +2.1% |
| Shares Outstanding | September 30, 2025 | 394.45M | +3.5% | +0.6% |
- MARIMED INC. reported Total Revenue of $159.83 million for fiscal year 2025.
- MARIMED INC. showed an increase of +1.3% in Total Revenue compared to the prior fiscal year.
- MARIMED INC. reported Revenue (ASC 606) of $159.83 million for fiscal year 2025.
- MARIMED INC. showed an increase of +1.3% in Revenue (ASC 606) compared to the prior fiscal year.
- MARIMED INC. reported Net Income of -$14.48 million for fiscal year 2025.
- MARIMED INC. showed a decrease of -16.2% in Net Income compared to the prior fiscal year.
- MARIMED INC. reported Diluted EPS of $0.04 per share (loss) for fiscal year 2025.
- MARIMED INC. showed a decrease of -33.3% in Diluted EPS compared to the prior fiscal year.
- MARIMED INC. reported Total Assets of $202.56 million for fiscal year 2025.
- MARIMED INC. showed a decrease of -2.1% in Total Assets compared to the prior fiscal year.
- MARIMED INC. reported Cash and Equivalents of $7.28 million for fiscal year 2024.
- MARIMED INC. showed a decrease of -50.3% in Cash and Equivalents compared to the prior fiscal year.
- MARIMED INC. reported Stockholders Equity of $50.01 million for fiscal year 2025.
- MARIMED INC. showed a decrease of -14.6% in Stockholders Equity compared to the prior fiscal year.
- MARIMED INC. reported R&D Expense of $93.1 thousand for fiscal year 2015.
- MARIMED INC. reported Operating Income of -$2.82 million for fiscal year 2025.
- MARIMED INC. showed a decrease of -208.1% in Operating Income compared to the prior fiscal year.
- MARIMED INC. reported Gross Profit of $57.88 million for fiscal year 2025.
- MARIMED INC. showed a decrease of -7.6% in Gross Profit compared to the prior fiscal year.
- MARIMED INC. reported Shares Outstanding of 396.91 million shares for fiscal year 2025.
- MARIMED INC. showed an increase of +4.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: